TLDR
- Barclays has shifted its stance on Nike (NKE) to overweight, increasing the price target from $64 to $73
- Shares have declined approximately 25% in the trailing 12-month period, trading at decade lows
- The company’s North American division delivered 9% revenue growth last quarter, though profits dropped 31% annually
- Q3 FY2026 results arrive March 31, representing a critical test for recovery prospects
- The investment bank suggests negative sentiment may have reached maximum levels
Nike’s recent performance has been challenging to say the least. Over the last year, shares have tumbled roughly 25%, settling near their lowest point in a decade — an uncomfortable position for one of the world’s most iconic consumer brands.
The athletic apparel giant faces pressure from multiple directions simultaneously. Revenue growth has disappointed, competitive threats from both established players and upstart brands are intensifying, and leadership changes have injected additional uncertainty into the equation. Add tariff concerns and weakening consumer confidence into the mix, and the investment case has looked increasingly shaky — that is, until recently.
This past Monday, Barclays revised its outlook on NKE shares, moving to an overweight rating while boosting the price objective to $73 from a previous $64. The analysts highlighted operational improvements, strengthening financial metrics, and enhanced management discipline as emerging evidence that the company may be beginning to stabilize.
The firm also made a notable observation: investor negativity surrounding the stock appears to have reached its maximum point — implying limited downside from current levels.
North America Shows Life While Profitability Lags
The financial picture presents contrasting signals. During the latest reporting period, Nike’s North American business delivered 9% revenue expansion, with the region posting 6% growth across the most recent six-month span. These figures represent genuine progress.
However, profitability hasn’t kept pace. Combined net income for the previous two quarters totaled $1.5 billion, representing a 31% year-over-year decline. Escalating expenses are offsetting whatever revenue gains the business manages to generate.
This disconnect between top-line momentum and bottom-line results continues to give many market participants pause.
March 31 Looms Large
The company’s upcoming Q3 FY2026 earnings release on March 31 represents a pivotal moment. Nike will be reporting results against relatively weak prior-year comparisons, which could potentially flatter year-over-year metrics.
Whether improved numbers signal authentic business momentum or simply reflect easier comparisons remains to be determined. Certain analysts believe conditions are favorable for an earnings surprise. Others highlight persistent macroeconomic challenges — including consumer downtrading and tariff complications — as justification for maintaining a cautious stance.
The Barclays upgrade shouldn’t be interpreted as an unqualified endorsement. The firm explicitly acknowledged that risks remain. However, the upgrade does signal that at present valuations, negative factors may be adequately reflected in the share price.
The stock currently trades at price levels last observed a decade ago. Some view this as a red flag signaling deeper problems. Others see it as an attractive entry point for a potential rebound.
Nike’s earnings announcement is scheduled for March 31.


